Sep 16, 2019
BioVentrix Announces the Appointment of Pedro Marques as VP of Sales in Europe
Sep 10, 2019
Crypto.com Adds Global Top-up via Wire Transfer for 21 Major Currencies
Sep 04, 2019
Astrocast Announces a Series A Funding Round of CHF 9M to Go Commercial
Aug 28, 2019
Liberty HomeCare and Hospice Achieves 7.1% 30-Day All-Cause Hospital Readmission Rate with HRS
Aug 23, 2019
mycasino.ch - the Online Casino from the Heart of Switzerland is Live
Aug 21, 2019
Assembl Announces Investment from CV VC to Build Decentralized Tools for Open Science
Aug 19, 2019
Asset Management Study 2019: Sustainable Investments and Product Specialisation as Opportunities
Aug 14, 2019
U.S. News & World Report Names Blessing Hospital a High Performing Hospital for Two Chronic Conditions
Aug 09, 2019
RUAG Space and Kubos Partner to Build The Next Generation of Megaconstellations
Aug 08, 2019
3D Systems and GF Machining Solutions Expand Partnership in Greater China - Enabling Customers in World's Top Manufacturing Region to Redefine Production Environments
Aug 06, 2019
BioVentrix Announces Key Additions to Leadership Team
Aug 05, 2019
Roche to showcase how health networks are driving change through innovation in the lab and beyond at AACC 2019 Clinical Lab Expo
Aug 01, 2019
Leviticus Cardio Appoints Prof. Nir Uriel to its Scientific Advisory Board
Jul 18, 2019
Amgen And Allergan's MVASI(TM) (bevacizumab-awwb) And KANJINTI(TM) (trastuzumab-anns) Now Available In The United States
Jul 16, 2019
Leviticus Cardio Appoints Prof. Mandeep R. Mehra to Its Scientific Advisory Board
Jul 01, 2019
Aethlon Medical, Inc. and SeaStar Medical, Inc. Announce Strategic Joint Cross-Licensing Agreement
Jun 27, 2019
Sika Sarnafil Committed to Vinyl's Sustainability Initiative
Jun 26, 2019
How New Proactive Telecare(TM) Is Transforming Home Healthcare
Jun 17, 2019
Roche Diabetes Care unveils a national survey reporting that people living with diabetes deal with a significantly higher level of stress
Jun 13, 2019
FDA Approves Amgen And Allergan's KANJINTI(TM) (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab)